FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,276 letters match. Newest first.
-
DrugsFei Fah Medical Manufacturing Pte. Ltd.
FDA warned Fei Fah Medical Manufacturing over inadequate stability data, unvalidated test methods, and supplier testing failures for over-the-counter drugs.
High risk -
DrugsKobayashi Healthcare International, Inc.
Kobayashi's Georgia plant released Zim's OTC pain drugs without microbial testing and lacked quality unit oversight, FDA says.
High risk -
DrugsMohawk Laboratories Division of NCH Corporation
FDA warns Mohawk Laboratories that its hand sanitizer contained unacceptable acetaldehyde and acetal impurities.
High risk -
DrugsUrban Electric Power
Urban Electric Power hand sanitizers contained unacceptable acetaldehyde and acetal impurities and had CGMP violations.
High risk -
DrugsBuzzagogo, LLC
Buzzagogo's Allergy Bee Gone for Kids nasal swab is an unapproved new drug contaminated with Bacillus bacteria.
High risk -
DrugsLarkin Community Hospital Institutional Review Board
Larkin Community Hospital IRB cited for approving trials without required nonscientist member and incomplete records.
Medium -
DrugsNorth American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding
FarmaKeio, a Texas compounding pharmacy, made sterile drugs under insanitary conditions that put patients at risk.
High risk -
DrugsHIS Enterprise Inc dba Adam’s Secret USA, LLC
FDA: Adam's Secret and Dr. Reade Slim Sense supplements sold online contain hidden prescription drugs tadalafil, sildenafil and lorcaserin.
High risk -
DrugsOptum Infusion Services 308 LLC
FDA warned Optum Infusion Services 308 LLC about insanitary conditions in sterile drug compounding after inspection found vermin and microbial contamination.
High risk -
DrugsMedical Mikes, Inc.
FDA and FTC warned Medical Mikes over unapproved CBD claims to prevent or treat COVID-19.
High risk -
DrugsPurecraft LLC
FDA and FTC warn Purecraft LLC over CBD products marketed with unapproved COVID-19 prevention and treatment claims.
High risk -
DrugsDistributor RFR, LLC
FDA: Distributor RFR's SANGTER male energy supplement contained undeclared sildenafil, making it an unapproved, misbranded new drug.
High risk -
Drugspharmahealthonline.com
FDA warned pharmahealthonline.com for selling unapproved, misbranded opioid and benzodiazepine drugs to U.S. consumers online.
High risk -
DrugsAuto-Chlor System LLC
Auto-Chlor System LLC made hand sanitizer under poor manufacturing practices and sold it as an unapproved, misbranded new drug.
High risk -
DrugsPharmaCanna
FDA and FTC warn PharmaCanna over CBDefense 2000, a cannabinoid product claimed to prevent or treat COVID-19 without approval.
High risk -
Drugsglobalpharmacyplus.com
FDA warned globalpharmacyplus.com in Canada for selling unapproved and misbranded prescription drugs to U.S. consumers online.
High risk -
DrugsSuperior Glove Works, Ltd.
Canada's Superior Glove Works made hand sanitizers with ethanol containing unsafe acetaldehyde levels and skipped required testing, FDA says.
High risk -
DrugsGreen Pharmaceuticals Inc.
FDA found Green Pharmaceuticals' SnoreStop NasoSpray contaminated with Providencia rettgeri and sold as an unapproved new drug.
High risk -
DrugsMD Pharmaceutical Supply, LLC
FDA warns MD Pharmaceutical Supply over API repackaging failures, including redistributing a returned lot and uncontrolled cross-contamination risks.
High risk -
DrugsAdarsh Daswani, M.D.
Clinical investigator Adarsh Daswani, M.D. failed to follow protocol dosing and oversight for an investigational drug study.
High risk -
DrugsNortec Quimica SA
FDA warned Brazil's Nortec Quimica, an API maker, over deleted lab data and weak quality unit review of batches exported to the U.S.
High risk -
DrugsDuPont Nutrition USA Inc.
FDA found DuPont released Avicel excipient that failed conductivity limits, citing weak investigations and data integrity lapses.
High risk -
DrugsSagent Pharmaceuticals, Inc.
FDA found SterRx, acquired by Sagent, made sterile drugs under conditions that risked contamination and lacked sterility assurance.
High risk -
DrugsCentrient Pharmaceuticals India Private Limited
Centrient Pharmaceuticals India's API plant drew FDA CGMP violations, including weak records and unproven beta-lactam contamination testing.
High risk -
DrugsThriftmaster Texas, LLC. d/b/a ThriftMaster Global Holdings, Inc. and TM Global Biosciences, LLC
FDA warned Thriftmaster Texas over unapproved CBD drugs and CBD-added foods, citing disease and COVID-19 claims and an unsafe food additive.
High risk -
DrugsKari Gran Inc.
Kari Gran Inc. released OTC SPF sunscreen drugs without adequate batch testing or stability data.
High risk -
DrugsAG Hair Limited
FDA warned AG Hair Limited over CGMP failures for hand sanitizer drugs, including inadequate investigations, microbiological controls, and component testing.
High risk -
DrugsGlenmark Pharmaceuticals Limited
FDA cited Glenmark's Goa plant for poor investigations, weak process validation, lab data controls, and incomplete batch records.
High risk -
Drugs"David M. Lubeck, M.D./Arbor Centers for EyeCare
FDA warned Dr. David Lubeck for running a combination-drug study without an IND and enrolling five subjects.
High risk -
DrugsShuzy Rock Inc.
FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.
High risk -
Drugsyourtramadol.com
FDA warned yourtramadol.com for selling unapproved and misbranded tramadol opioid products to U.S. consumers online.
High risk -
Drugsgoodimmuno.com
FDA warned goodimmuno.com for selling unapproved, misbranded tramadol and diazepam online without prescriptions.
High risk -
DrugsThe Anthos Group, Inc.
Anthos Group refused FDA access to OTC drug records for VERTRA Hand Sanitizer, FDA says.
Medium -
DrugsOmega & Delta Co., Inc.
FDA says Omega & Delta's hand sanitizers were made under unsanitary conditions and with serious manufacturing quality failures.
High risk -
DrugsAbraxis Bioscience LLC
FDA warned Abraxis Bioscience about repeated contamination in media fills for sterile Abraxane at its Phoenix plant.
High risk -
DrugsNatureLab Corp.
FDA warned NatureLab Corp., a Carrollton, Texas dietary supplement maker, that its products are adulterated from CGMP violations and misbranded.
Medium -
DrugsAlternative Health Distribution LLC d/b/a CannaAid
FDA and FTC warned CannaAid over website claims that CBD/cannabinoid products prevent or treat COVID-19.
High risk -
DrugsLatin Foods Market
Latin Foods Market sold Artri King Reforzado con Ortiga y Omega 3, an unapproved drug with undeclared diclofenac and dexamethasone.
High risk -
DrugsWalmart Inc.
Walmart sold Artri King, a joint supplement containing undeclared diclofenac, making it an unapproved and misbranded new drug.
High risk -
DrugsAmazon.com, Inc.
Amazon sold three "Artri" and "Ortiga" arthritis supplements that lab tests found contained undisclosed diclofenac, an unapproved drug.
High risk -
DrugsNephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center, LLC
FDA warned Nephron Sterile Compounding Center about insanitary sterile drug production and sterility assurance failures found in a 2022 inspection.
High risk -
DrugsMcConnell Labs Inc.
McConnell Labs Inc. released hand sanitizers without raw material identity, finished product, or stability testing, FDA says.
High risk -
DrugsSovereign Pharmaceuticals, LLC
FDA cited Sovereign Pharmaceuticals for manufacturing failures in bulk tablets, inadequate out-of-specification (OOS) investigations, quality-unit lapses, and an unapproved biological product.
High risk -
DrugsLupin Limited
FDA warned Lupin Limited of current good manufacturing practice (CGMP) violations at its Tarapur API plant involving cleaning and genotoxic impurity controls.
High risk -
DrugsLakpura LLC
FDA and Federal Trade Commission warned Lakpura LLC over ayurvedic products and teas with unapproved COVID-19 claims.
High risk -
DrugsUnit Dose Services, LLC
Unit Dose Services of Miami, Florida, listed Lisinopril with a carton label image showing a different drug, acetaminophen.
Low -
DrugsNephron SC Inc.
Nephron SC's sterile drug manufacturing had unresolved cross-contamination and microbial contamination, making its drugs adulterated.
High risk -
DrugsAdvanced Cosmetic Research Laboratories Inc.
FDA cited Advanced Cosmetic Research Laboratories for manufacturing-quality violations at its Chatsworth drug plant and an unapproved 5% lidocaine cream.
High risk -
DrugsBeijing Xinggu Lvsan Technology Co., Ltd. Formerly known as Beijing Lvsan Technology Co., Ltd.
FDA cites Beijing Xinggu Lvsan for manufacturing-rule failures and unapproved, misbranded hand sanitizers.
High risk -
DrugsAmerican Cleaning Solutions
FDA warned American Cleaning Solutions after a 2022 inspection found hand sanitizer made with inadequate cleaning, unvalidated processes, and substituted ethanol.
High risk